Microdroplets for drug discovery and delivery targeting neural models

Simple item page
dc.contributor.authorForigua Coronado, Alejandro
dc.contributor.supervisorElvira, Katherine S.
dc.date.accessioned2024-01-31T17:14:39Z
dc.date.copyright2024en_US
dc.date.issued2024-01-31
dc.degree.departmentDepartment of Chemistry
dc.degree.levelDoctor of Philosophy Ph.D.en_US
dc.description.abstractThis dissertation explores the application of microdroplet technology in two pivotal areas of the pharmaceutical and biotechnological fields: drug discovery and drug delivery, with a focus on neural models. It presents a comprehensive study on the development and application of microfluidic devices for the fabrication of drug delivery particles and the modeling of cell membranes using Droplet Interface Bilayers (DIBs). The first part of this work, detailed in Chapters 2 and 3, describes the design and optimization of a Polydimethylsiloxane (PDMS) microfluidic platform for generating oil-in-water droplets. These droplets serve as precursors for polycaprolactone (PCL) microparticles, which have potential for controlled drug release. This platform showcases significant improvements in droplet generation and encapsulation efficiency compared to traditional batch processes and has been adopted for commercial-scale production. In the second part, Chapters 4 and 5 focus on the application of DIBs as a model for cell membranes. The research quantitatively analyzes the passive diffusion of memantine, an Alzheimer’s disease treating drug, and niacin, a common vitamin supplement used as a neuroprotective agent, and examines the impact of lipid formulation and droplet content on drug absorption and water transport. The findings highlight the advantages of using biomimetic lipid formulations for in vitro studies. This dissertation demonstrates the significant potential of microdroplet technology in enhancing the efficacy and precision of drug delivery systems and in providing more accurate models for cell membrane studies. The insights gained not only contribute to the academic understanding of drug interaction with cellular membranes but also pave the way for future innovations in neuropharmacology and biotechnology.en_US
dc.description.embargo2027-01-12
dc.description.scholarlevelGraduateen_US
dc.identifier.bibliographicCitationA. Forigua, R. L. Kirsch, S. M. Willerth and K. S. Elvira, “Recent advances in the design of microfluidic technologies for the manufacture of drug releasing particles”, Journal of Controlled Release, 2021, 333, 258–268. DOI: 10.1016/j.jconrel.2021.03.019en_US
dc.identifier.bibliographicCitationA. Forigua, A. Dalili, R. Kirsch, S. M. Willerth and K. S. Elvira, “Microfluidic generation of therapeutically relevant polycaprolactone (PCL) microparticles: Computational and experimental approaches”, ACS Applied Polymer Materials, 2022, 4, 7004–7013. DOI: 10.1021/acsapm.2c00943en_US
dc.identifier.urihttp://hdl.handle.net/1828/15914
dc.languageEnglisheng
dc.language.isoenen_US
dc.rightsAvailable to the World Wide Weben_US
dc.subjectDropletsen_US
dc.subjectDrug deliveryen_US
dc.subjectMicrofluidicsen_US
dc.subjectNeural modelsen_US
dc.subjectBiomemebranesen_US
dc.subjectBiophysicsen_US
dc.subjectDrug discoveryen_US
dc.subjectMicroparticlesen_US
dc.subjectBiotechnologyen_US
dc.titleMicrodroplets for drug discovery and delivery targeting neural modelsen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Forigua Coronado_Alejandro_PhD_2024.pdf
Size:
20.65 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Electronic Theses and Dissertations (ETD)
 
University of Victoria Libraries

We acknowledge and respect the Lək̓ʷəŋən (Songhees and Esquimalt) Peoples on whose territory the university stands, and the Lək̓ʷəŋən and W̱SÁNEĆ Peoples whose historical relationships with the land continue to this day.